Universe Pharmaceuticals INC (UPC) stock
UPCNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 20-F on Jan 29, 2026Score 5/30
$1.36−0.16 (-10.60%)
Close on Nov 19, 2026Market cap $766.14KP/E –Yield –
Universe Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $17.86B, down 22.4% from the year before. The highest annual figure on record is $32.31B in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $17.86B | -22.4% |
| FY2024 | Sep 30, 2024 | $23.02B | -28.7% |
| FY2023 | Sep 30, 2023 | $32.31B | +80383.8% |
| FY2022 | Sep 30, 2022 | $40.14M | -16.3% |
| FY2021 | Sep 30, 2021 | $47.98M | +56.3% |
| FY2020 | Sep 30, 2020 | $30.70M | -7.6% |
| FY2019 | Sep 30, 2019 | $33.23M | – |
See a number that looks wrong?